Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage ...
Read moreWESTLAKE VILLAGE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage ...
Read moreSurge Energy US Holdings Company ('Surge Energy' or the 'Company') today announced that it was listed ...
Read moreCEO of the SoftBank Group Masayoshi Son speaks at a new conference in London, Britain July ...
Read moreStaffing 360 Solutions, Inc.Common Stock Will Begin Trading on Split-Adjusted Basis on June 24, 2022NEW YORK, June 23, ...
Read moreBy Giulia Petroni Industrie De Nora SpA said Monday that it seeks a valuation of up ...
Read moreBy Josh Beckerman Euro Tech Holdings Co., which was recently added to a provisional Securities and ...
Read moreTORONTO, April 5, 2022 /PRNewswire/ - Electra Battery Materials Corporation (TSXV: ELBM) (OTCQX: ELBMF) ("Electra") announced ...
Read moreBy Joe Hoppe Bacanora Lithium PLC said Thursday that it has requested the London Stock Exchange ...
Read moreFLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage ...
Read moreBEDFORD, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint ...
Read more© 2022 TheDailyStock.News